Healthcare
Live Price
Offline$0.9434
-21.71% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Columbia Care Inc. (CCHWF) is a Healthcare stock with a market cap of $521.35M. The stock last traded around $0.94. Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin -9.4% and ROIC -6.0%. Valuation is more restrained than many high-expectation growth names at price/sales 1.6. Stock Foundry combines CCHWF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CCHWF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CCHWF Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CCHWF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$77.5M
-56.8% YoY
FY Net Income
-$106.7M
+19.9% YoY
Free Cash Flow
-$137.2M
-60.5% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
30.7%
Net Margin
-12.3%
Income statement
USD
| Metric | 2024 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 459M | 512M | 460M | 180M | 77M |
| Gross Profit | 168M | 201M | 194M | 66M | 37M |
| Operating Income | -22M | -416M | -39M | -74M | -82M |
| EBITDA | -22M | -294M | 7M | -32M | -56M |
| Net Income | -106M | -421M | -147M | -133M | -107M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 34M | 48M | 82M | 61M | 47M |
| Total Assets | 696M | 995M | 1.4B | 793M | 402M |
| Total Liabilities | 726M | 788M | 826M | 471M | 135M |
| Shareholder Equity | -30M | 207M | 571M | 342M | 268M |
| Total Debt | 229M | 567M | 421M | 295M | 84M |
| Net Debt | 195M | 519M | 339M | 234M | 36M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
60M
-40.2% YoY
Capital Expenditures
77M
-80.6% YoY
Free Cash Flow
137M
-60.5% YoY
Key ratios
Gross Margin
30.7%
Operating Margin
-9.4%
Net Margin
-12.3%
ROE
42.3%
Debt / Equity
-0.94x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.